Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy
University of Texas Southwestern Medical Center
67 participants
Mar 14, 2024
INTERVENTIONAL
Conditions
Summary
To compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
42.5 Gy in 5 fractions Low-risk: twice/week Moderate-risk: weekly
63 Gy in 28 fractions (T1) 65.25 Gy in 29 fractions (T2)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06080503